EUVIMEDEUVIMED entdecken
Open Access

Ultrasound priming gated by solid tumor hallmarks to guide CAR-T therapy

Tianze Guo iD, Ziyue Zhu, Yunjia Qu, Xi Yu iD, Linshan Zhu iD, Yuxuan Wang, Kunshu Liu, Jiaxin Cui iD, Xue Dong iD, Chi-Woo Yoon iD, Cem Yigit Kilic iD, Peixiang He iD und 9 weitere

Science Advances · 12.06.2026 · 12 (24)

DOI: 10.1126/sciadv.aed0666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 12.06.2026. Verfasst von Tianze Guo und 20 weiteren Autor:innen. Beteiligte Einrichtung: Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Neoplasms. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR-T therapy is highly effective in hematologic malignancies but remains challenging in solid tumors. To address this challenge, here, we developed SHIFTERS (solid-tumor hallmark inducible, focused-ultrasound triggered enhanced reprogramming system), an AND-gated circuit that rewires tumor hallmarks into the clinically validated antigen CD19 under focused-ultrasound (FUS) control. SHIFTERS uses a split Gal4-VP64 transcription factor with one module driven by a hypoxia-responsive promoter and the other by a FUS-inducible heat-shock promoter, restricting CD19 induction to sonicated, hallmark-positive regions. This design enables robust, sustained local CD19 expression to activate and train CD19 synNotch CAR-T cells. In 3D spheroids and in vivo models, hypoxia-gated SHIFTERS combined with synNotch CAR-T cells achieved strong tumor suppression, supporting FUS-guided, localized activation. SHIFTERS is modular and can be adapted to tumor-type–specific promoters such as enAFP in hepatocellular carcinoma to enable both spatial and cell type–specific targeting. Together, SHIFTERS provides a modular, tumor-constrained, ultrasound-controllable platform to improve the precision and efficacy of CAR-T therapy for solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Chimeric AntigenNeoplasmsAnimalsHumansMicePromoter Regions, GeneticCell Line, TumorXenograft Model Antitumor Assays

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.
  • Shu Chien-Gene Lay Department of Bioengineering, Institute of Engineering in Medicine, University of California, San Diego, CA, USA.
  • Department of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Aerospace and Mechanical Engineering, University of Southern California, Los Angeles, CA, USA.
  • Department of Statistics and Data Science, University of California, Los Angeles, Los Angeles, CA, USA.

ORCID-Profile: Tianze Guo, Xi Yu, Linshan Zhu, Jiaxin Cui, Xue Dong, Chi-Woo Yoon, Cem Yigit Kilic, Peixiang He, Yushun Zeng, Qifa Zhou, Ishwar K Puri, Longwei Liu, Keyue Shen, Yingxiao Wang

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Guo, T., Zhu, Z., Qu, Y., Yu, X., Zhu, L., Wang, Y., Liu, K., Cui, J., Dong, X., Yoon, C. W., Kilic, C. Y., He, P., Gou, S., Zeng, Y., Datta, P., Zhou, Q., Xu, H., Puri, I. K., Liu, L., …, & Wang, Y. (2026). Ultrasound priming gated by solid tumor hallmarks to guide CAR-T therapy. Science Advances, 12(24). https://doi.org/10.1126/sciadv.aed0666

Vancouver

Guo T, Zhu Z, Qu Y, Yu X, Zhu L, Wang Y, et al. Ultrasound priming gated by solid tumor hallmarks to guide CAR-T therapy. Science Advances. 2026;12(24). doi:10.1126/sciadv.aed0666

BibTeX
@article{Guo2026,
  author = {Guo, Tianze and Zhu, Ziyue and Qu, Yunjia and Yu, Xi and Zhu, Linshan and Wang, Yuxuan and Liu, Kunshu and Cui, Jiaxin and Dong, Xue and Yoon, Chi-Woo and Kilic, Cem Yigit and He, Peixiang and Gou, Shuangquan and Zeng, Yushun and Datta, Priyankan and Zhou, Qifa and Xu, Hongquan and Puri, Ishwar K and Liu, Longwei and Shen, Keyue and Wang, Yingxiao},
  title = {Ultrasound priming gated by solid tumor hallmarks to guide CAR-T therapy},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {24},
  doi = {10.1126/sciadv.aed0666}
}
Kostenlos starten →